Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
Medicines.ie | Reliable & Accurate Online Medicines Information | Home page
Home Medicines Active Ingredients Companies DHPC Advanced Search Side Effect Reporting
Login
  • Home
  • Active Ingredients
  • Tapentadol Hydrochloride

Tapentadol Hydrochloride

Medicine Status Monitoring SPC PIL XPIL Legal Category Active Ingredient(s) Company
Palexia 100 mg film-coated tablets
No Recent Update
SPC PIL Yes A
Tapentadol Hydrochloride
Grunenthal Pharma Ltd.
Palexia 50 mg film-coated tablets
No Recent Update
SPC PIL Yes A
Tapentadol Hydrochloride
Grunenthal Pharma Ltd.
Palexia 75 mg film-coated tablets
No Recent Update
SPC PIL Yes A
Tapentadol Hydrochloride
Grunenthal Pharma Ltd.
Palexia Oral Solution 20 mg/ml
No Recent Update
SPC PIL Yes A
Tapentadol Hydrochloride
Grunenthal Pharma Ltd.
Palexia Oral Solution 4mg/ml
No Recent Update
SPC PIL Yes A
Tapentadol Hydrochloride
Grunenthal Pharma Ltd.
Palexia SR 100 mg prolonged-release tablets
No Recent Update
SPC PIL Yes A
Tapentadol Hydrochloride
Grunenthal Pharma Ltd.
Palexia SR 150 mg prolonged-release tablets
No Recent Update
SPC PIL Yes A
Tapentadol Hydrochloride
Grunenthal Pharma Ltd.
Palexia SR 200 mg prolonged-release tablets
No Recent Update
SPC PIL Yes A
Tapentadol Hydrochloride
Grunenthal Pharma Ltd.
Palexia SR 250 mg prolonged-release tablets
No Recent Update
SPC PIL Yes A
Tapentadol Hydrochloride
Grunenthal Pharma Ltd.
Palexia SR 50 mg prolonged-release tablets
No Recent Update
SPC PIL Yes A
Tapentadol Hydrochloride
Grunenthal Pharma Ltd.

Brought to you by

Irish Pharmaceutical Healthcare Association | Home page

About

  • Help
  • About
  • Contact Us

Legal

  • Privacy Statement
  • Terms & Conditions
  • Accessibility

Search

  • Medicines
  • Active Ingredients
  • Companies

Award

Pharma Industry Awards 2020, Innovation of the Year, 2nd Place
Designed by eConcept Web Solutions
Direct Healthcare Professional Communications
The Summary of Product Characteristics (SPC) is a specific document, the wording of which has been agreed with the regulatory authority as part of the medicine approval process. It is required before any medicine is allowed on the market in Europe. It is designed to assist doctors and pharmacists in prescribing and supplying the product.
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
This medicine and its document have not been updated in the last 30 days.
''Company'' may refer to either the Marketing Authorization Holder (MAH), the company responsible for marketing the product in Ireland and/or responsible for uploading documents pertaining to the product onto Medicines.ie. To determine the MAH, please consult the actual submitted documents.
Product subject to medical prescription which may not be renewed (A)